IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy. (Q55460980)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

chemoradiotherapy

0 references

0 references

anaplastic astrocytoma

1 reference

based on heuristic

inferred from title

Antonietta Arcella

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Veronica Villani

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Vincenzo Esposito

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Felice Giangaspero

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Giuseppe Minniti

1

object named as

Giuseppe Minniti

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Riccardo Maurizi Enrici

14

object named as

Riccardo Maurizi Enrici

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Claudia Scaringi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Gaetano Lanzetta

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Domenica Di Stefano

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Stefania Scarpino

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Alessandro Bozzao

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Maurizio Salvati

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

20 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

118

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

377-383

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

https://scigraph.springernature.com/pub.10.1007/s11060-014-1443-0

0 references

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Diagnosis and treatment of high-grade astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1443-0

21 January 2018

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24748470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24748470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for high-grade glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24748470

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1443-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24748470%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55460980&oldid=2084401038"